The single-arm INVEST-CTO study showed high procedural success with a two-part intervention, but questions remain.

For optimal 1-year results, in patients with prior coronary artery bypass grafting who need percutaneous coronary ...

DENVER, CO—For patients receiving optimal medical therapy, stenting a chronic total occlusion (CTO) does not provide a boost in either regional or global LV function, the REVASC trial shows. The ...

PARIS — Findings from the prospective Consistent CTO study offer a bit of optimism for complex chronic total occlusion (CTO) percutaneous coronary intervention (PCI) in highly symptomatic patients. In ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. In patients who undergo PCI for STEMI, additional PCI ...

The hybrid approach opened chronic total occlusion (CTO) in almost 9 of 10 patients, despite the initial crossing strategy being successful in only 55% of cases, in what is thought to be the largest ...

ATLANTA, GA (May 20, 2022) – A new analysis of PROGRESS-CTO (PROspective Global REgiStry for the Study of Chronic Total Occlusion Intervention; www.progresscto.org), an international multi-center ...

WAYNE, Pa., June 02, 2020 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the first patient enrollment in a clinical study ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window PARIS -- ...

View the full release here: "With a similar safety profile, OPN can be a feasible and faster alternative to IVL." Dr. M. Bossard, Senior Physician at Luzerner Kantonsspital, Switzerland A total of ...

Study Will Evaluate the Performance of Teleflex Coronary Guidewires and Specialty Catheters in Patients Undergoing Chronic Total Occlusion Percutaneous Coronary Interventions WAYNE, Pa., June 02, 2020 ...